Literature DB >> 1599934

Identification of the bactericidal domain of lactoferrin.

W Bellamy1, M Takase, K Yamauchi, H Wakabayashi, K Kawase, M Tomita.   

Abstract

We report the existence of a previously unknown antimicrobial domain near the N-terminus of lactoferrin in a region distinct from its iron-binding sites. A single active peptide representing this domain was isolated following gastric pepsin cleavage of human lactoferrin, and bovine lactoferrin, and sequenced by automated Edman degradation. The antimicrobial sequence was found to consist mainly of a loop of 18 amino acid residues formed by a disulfide bond between cysteine residues 20 and 37 of human lactoferrin, or 19 and 36 of bovine lactoferrin. Synthetic analogs of this region similarly exhibited potent antibacterial properties. The active peptide of bovine lactoferrin was more potent than that of human lactoferrin having effectiveness against various Gram-negative and Gram-positive bacteria at concentrations between 0.3 microM and 3.0 microM, depending on the target strain. The effect of the isolated domain was lethal causing a rapid loss of colony-forming capability. Our studies suggest this domain is the structural region responsible for the bacterial properties of lactoferrin.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1599934     DOI: 10.1016/0167-4838(92)90346-f

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  149 in total

Review 1.  Perspectives on bifidobacteria as biotherapeutic agents in gastrointestinal health.

Authors:  L C Duffy; A Leavens; E Griffiths; D Dryja
Journal:  Dig Dis Sci       Date:  1999-08       Impact factor: 3.199

2.  N-Acylated and D enantiomer derivatives of a nonamer core peptide of lactoferricin B showing improved antimicrobial activity.

Authors:  H Wakabayashi; H Matsumoto; K Hashimoto; S Teraguchi; M Takase; H Hayasawa
Journal:  Antimicrob Agents Chemother       Date:  1999-05       Impact factor: 5.191

3.  Positive selection drives lactoferrin evolution in mammals.

Authors:  Guo Ming Liang; Xun Ping Jiang
Journal:  Genetica       Date:  2010-04-18       Impact factor: 1.082

4.  Lactoferrin concentration in milk of bovine clinical mastitis.

Authors:  K Kawai; S Hagiwara; A Anri; H Nagahata
Journal:  Vet Res Commun       Date:  1999-11       Impact factor: 2.459

5.  Coadsorption of human milk lactoferrin into the dipalmitoylglycerolphosphatidylcholine phospholipid monolayer spread at the air/water interface.

Authors:  Fausto Miano; Xiubo Zhao; Jian R Lu; Jeff Penfold
Journal:  Biophys J       Date:  2006-11-17       Impact factor: 4.033

6.  The survival of ingested lactoferrin in the gastrointestinal tract of adult mice.

Authors:  H Kuwata; T T Yip; K Yamauchi; S Teraguchi; H Hayasawa; M Tomita; T W Hutchens
Journal:  Biochem J       Date:  1998-09-01       Impact factor: 3.857

7.  Rational design of a biomimetic cell penetrating peptide library.

Authors:  Emmanouil D Karagiannis; Aleksandra M Urbanska; Gaurav Sahay; Jeisa M Pelet; Siddharth Jhunjhunwala; Robert Langer; Daniel G Anderson
Journal:  ACS Nano       Date:  2013-09-30       Impact factor: 15.881

8.  Human milk secretory immunoglobulin a and lactoferrin N-glycans are altered in women with gestational diabetes mellitus.

Authors:  Jennifer T Smilowitz; Sarah M Totten; Jincui Huang; Dmitry Grapov; Holiday A Durham; Carol J Lammi-Keefe; Carlito Lebrilla; J Bruce German
Journal:  J Nutr       Date:  2013-09-18       Impact factor: 4.798

9.  Extensive in vivo human milk peptidomics reveals specific proteolysis yielding protective antimicrobial peptides.

Authors:  David C Dallas; Andres Guerrero; Nora Khaldi; Patricia A Castillo; William F Martin; Jennifer T Smilowitz; Charles L Bevins; Daniela Barile; J Bruce German; Carlito B Lebrilla
Journal:  J Proteome Res       Date:  2013-04-24       Impact factor: 4.466

10.  Inhibition of HBV infection by bovine lactoferrin and iron-, zinc-saturated lactoferrin.

Authors:  Songtao Li; Haibo Zhou; Guirong Huang; Ning Liu
Journal:  Med Microbiol Immunol       Date:  2008-09-23       Impact factor: 3.402

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.